The January Effect offers an opportunity to potentially make about 30% in three months. It is a phenomenon that makes prices of certain stocks rise more in January than the market averages. Over the last 30 years, we have made money from the January Effect about 75% of the time,
This post was just published on ZYX Buy Change Alert OREX is long for most subscribers from $4.50. OREX is moving up in the pre-market on the news of good enrollment numbers. This news was expected. We recommend taking advantage of this news. What To Do Now? Those who
The U.S. Food and Drug Administration (FDA) has approved the first obesity drug in 15 years. The drug is lorcaserin, dubbed Belviq, from Arena Pharmaceuticals (ARNA). The drug works by affecting the area of the brain that regulates metabolism. The issue with weight loss drugs has not been efficacy, rather
This post was published earlier on ZYX BuyChange Alert OREX is a sympathy play with ARNA. FDA has just approved ARNA weight loss drug. The risk is very high and this trade is only for aggressive investors. Buy zone is $3.90 -4.61. Stop zone is 3.43-3.73. Target zone is $6-7.50. This is